Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
97 |
|
| Actual shortage: | 2 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 12 (12%) | |
| Resolved: | 83 (86%) | |
Discontinuation Reports |
23 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 22 (96%) | |
| Reversed: | 1 (4%) | |
Late reports |
6 (5%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ULTRAVIST 300 | 62% | SOLUTION | Resolved | 2024-04-02 | 2024-12-16 | 224127 |
| ULTRAVIST 370 | 77% | SOLUTION | Resolved | 2024-02-07 | 2024-05-06 | 218759 |
| ULTRAVIST 370 | 77% | SOLUTION | Resolved | 2024-01-12 | 2024-08-21 | 215779 |
| ULTRAVIST 370 | 77% | SOLUTION | Resolved | 2024-01-12 | 2024-05-06 | 215787 |
| ULTRAVIST 370 | 77% | SOLUTION | Resolved | 2024-01-12 | 2024-03-14 | 215790 |
| VERQUVO | 2.5MG | TABLET | Resolved | 2024-10-24 | 2024-11-21 | 241108 |
| VITRAKVI | 100MG | CAPSULE | Resolved | 2025-02-20 | 2025-03-29 | 250914 |
| VITRAKVI | 100MG | CAPSULE | Resolved | 2023-04-28 | 2023-05-03 | 191158 |
| VITRAKVI | 25MG | CAPSULE | Resolved | 2023-04-20 | 2023-06-10 | 189904 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Avoided shortage | 2022-01-28 | 2022-02-09 | 153808 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2021-08-17 | 2021-11-30 | 144273 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2022-07-21 | 2022-08-08 | 165181 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-27 | 2022-11-23 | 172777 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2023-03-29 | 2023-06-05 | 188217 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Avoided shortage | 2023-06-29 | 2023-11-17 | 196859 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2024-01-11 | 2024-02-06 | 215608 |
| XARELTO | 2.5MG | TABLET | Resolved | 2021-05-04 | 2021-05-14 | 138713 |
| XARELTO | 51.7MG | GRANULES FOR SUSPENSION | Resolved | 2025-02-03 | 2025-02-12 | 249440 |
| XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-24 | 2022-10-29 | 167663 |
| XARELTO | 103.4MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-29 | 2023-11-17 | 196862 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-07-14 | 2023-07-14 | 198701 |
| ULTRAVIST 240 | 50% | SOLUTION | Discontinued | 2019-04-17 | 2019-04-17 | 81959 |
| XARELTO | 15MG 20MG | TABLET KIT | Discontinued | 2018-12-05 | 2018-12-05 | 68808 |